A former hedge fund manager has been found guilty of involvement in what US prosecutors say was the largest-ever insider trading scheme.
Mathew Martoma used secrets from the clinical trials of a new drug for Alzheimer's to earn $275m.
His lawyer says an appeal is planned against the possible 20 year prison sentence.
Al Jazeera's Kristen Saloomey reports from New York.
Source: Al Jazeera